IkBa is a dual regulator of Rel/NF-kB transcription factors. IkBa retains inactive NF-kB dimers in the cytoplasm, and inhibits their DNA-binding and transcriptional activities in the nucleus. Our previous studies identi®ed discrete functional domains in IkBa responsible for the cytoplasmic and nuclear regulation of c-Rel. Determinants necessary for regulating c-Rel in the nucleus mapped to the central ankyrin domain of IkBa and a few negatively-charged amino acids that follow in the C-terminal PEST region. In contrast, sequences involved in the cytoplasmic regulation of c-Rel reside in the N-terminal and central ankyrin domains of IkBa.
The vertebrate members of the Rel/NF-kB family of transcription factors are key regulators of immune, in¯ammatory and acute phase responses that also participate in cell growth control and dierentiation . These include c-Rel, p65/RelA, RelB, p105/NF-kB1, p100/NF-kB2 and the avian oncoprotein v-Rel. These subunits assemble into homodimers and heterodimers that reside in an inactive state in the cytoplasm, bound to one of several inhibitory IkB factors (Beg et al., 1992; Ganchi et al., 1992; Zabel et al., 1993) . The reception of an activating stimulus culminates in IkB protein degradation by the 26S proteasome. The end result is the release of active Rel dimers that migrate to the nucleus and bind to speci®c kB DNA sites to transactivate cellular gene expression (Kunsch et al., 1992) . The transcriptional activation of the gene encoding IkBa itself gives rise to an autoregulatory loop that serves to tightly control Rel protein activity (Brown et al., 1993; Le Bail et al., 1993; Scott et al., 1993; Sun et al., 1993; Chiao et al., 1994) . In the absence of cytosolic NF-kB, newly synthesized IkBa accumulates in the nucleus where it antagonizes NF-kB DNA contact and terminates the induction process (Arenzana-Seisdedos et al., 1995; Beg et al., 1995; Klement et al., 1996) . IkBa also promotes the relocalization of nuclear Rel dimers to the cytoplasm, owing to its nuclear export sequence (Arenzana-Seisdedos et al., 1997) .
Of the six mammalian IkB molecules described to date (IkBa, IkBb, IkBg, IkBe, IkBR, , IkBa is the best characterized. The N-terminal domain contains serine and lysine residues that target IkBa for degradation upon stimuli-induced phosphorylation and ubiquitination (Maniatis, 1997; Verma and Stevenson, 1997) . Its central domain contains six imperfect ankyrin repeats that mediate IkBa interaction with Rel dimers. Integrity of this region of IkBa and of the Rel dimerization domain is critical for the stability of the complex and the eciency of NF-kB sequestration (Inoue et al., 1992; Hatada et al., 1993; Latimer et al., 1998; Malek et al., 1998; Simeonidis et al., 1999) . The second ankyrin repeat functions as a nuclear localization sequence (NLS) for IkBa, whereas a leucine-rich sequence motif found in the sixth ankyrin repeat serves as a nuclear export signal that promotes the cytoplasmic relocalization of nuclear Rel dimers (Arenzana-Seisdedos et al., 1997; Sachdev et al., 1998) . The C-terminal domain of IkBa includes an acidic PEST region important for the integral stability of Ik Ba and for the inhibition of Rel DNA binding in the nucleus (Barroga et al., 1995; Ernst et al., 1995; Sachdev et al., 1995; Luque and GeÂ linas, 1998; Malek et al., 1998) .
While the N-terminal domain is critical for inducible degradation of IkBa and the consequent activation of NF-kB complexes, these sequences are dispensable for IkBa interaction with Rel dimers (Jaray et al., 1995; Sun et al., 1996; Latimer et al., 1998; Luque and GeÂ linas, 1998; Malek et al., 1998) . Recent work from this group and others suggested an additional function for the N-terminal domain of IkBa, by implicating it in the cytoplasmic localization of Rel/NF-kB dimers (Latimer et al., 1998; Luque and GeÂ linas, 1998) . Deletion of the N-terminal region of IkBa abolished its ability to restrict (c-Rel) 2 and (p50) 2 complexes in the cytosol. Immunoprecipitation assays using antibodies speci®c for the Rel NLS suggested exposure of the Rel nuclear targeting sequence when c-Rel was associated with N-terminal deletion mutants of IkBa (Luque and GeÂ linas, 1998) . At present, no other information is available on the determinants within this domain of IkBa responsible for the functional regulation of intact full-length Rel proteins.
To identify the IkBa determinants responsible for the cytoplasmic localization and functional inactivation of intact c-Rel homodimers, mutants carrying nested deletions in the N-terminal domain of IkBa were generated by site-directed mutagenesis (Figure 1a) . The capacity of these mutants to con®rm the full-length cRel protein to the cytoplasm was compared to that of wild-type IkBa in transiently transfected cells. Immuno¯uorescence analysis with an anti-c-Rel antibody showed predominant nuclear staining for c-Rel when expressed alone in COS-7 cells (Figure 1b, panel b) . As anticipated, greater than 85% of c-Rel-positive cells showed cytoplasmic c-Rel when co-transfected with wild-type IkBa (panel c). Similarly, c-Rel was con®ned to the cytoplasm when co-expressed with N-terminal IkBa mutants 14 ± 318, 28 ± 318 or 48 ± 318 (panels d ± f). These results highlighted the ability of these mutants to localize c-Rel in the cytoplasm and showed that residues 1 ± 48 in IkBa are not essential for this function. In sharp contrast, cells expressing IkBa mutants with further deletions in the N-terminal domain failed to accumulate c-Rel in the cytoplasm (mutants 59 ± 318, 76 ± 318 or 87 ± 318; Figure 1b , panels g ± i). When co-transfected with these mutants, c-Rel was primarily found in the nuclear compartment in at least 90% of c-Rel-positive cells. This indicated that residues located beyond amino acid 48 in the Nterminus of IkBa were necessary to control the subcellular localization of c-Rel.
We investigated whether the dierential eects of wild-type and mutant IkBa proteins resulted from dierences in their anity for c-Rel in co-immunoprecipitation assays. Extracts from COS-7 cells transfected with expression vectors for wild-type or mutant IkBa proteins together with c-Rel were immunoprecipitated with an antibody speci®c for the unique C-terminus of c-Rel (Ab1801; Kumar and GeÂ linas, 1993) . With the exception of mutant 87 ± 318, all of the N-terminally deleted mutants of IkBa associated eciently with cRel (Figure 2 , compare lanes 4 ± 8 to lane 3). This indicated that the N-terminal domain of IkBa is not required for interaction with c-Rel. This agreed with other reports (Jaray et al., 1995; Sun et al., 1996; Latimer et al., 1998; Luque and GeÂ linas, 1998; Malek et al., 1998) . In contrast IkBa mutant 87 ± 318 failed to co-immunoprecipitate with c-Rel (lane 9), despite the fact that the 87 ± 318 mutant protein was detected in Western blots (bottom panel, lane 9). The fact that this deletion also removed ten amino acids from the ®rst ankyrin repeat of IkBa is consistent with studies showing that an intact central ankyrin domain is essential for IkBa interaction with NF-kB factors (Haskill et al., 1991; Inoue et al., 1992; Hatada et al., 1993; Jaray et al., 1995; Luque and GeÂ linas, 1998) . Together with the immuno¯uorescence data, this indicated that residues beyond amino acid 48 in the N-terminal domain of IkBa are needed to localize cRel dimers in the cytoplasm, although they are not required for the formation of IkBa-(c-Rel) 2 complexes.
Next, functional assays examined the inhibitory activity of IkBa mutants toward c-Rel-mediated transactivation in vivo. COS-7 cells transfected with pCMV-c-Rel together with an IL6kBCAT reporter plasmid showed a tenfold activation of the promoter in comparison to control cells transfected with an empty CMV vector ( Figure 3a ). As anticipated, the co- . N-terminal mutants of IkBa 14 ± 318, 28 ± 318, 48 ± 318, 59 ± 318, 76 ± 318 and 87 ± 318 contained progressive N-terminal deletions and were generated using the`Altered Sites' mutagenesis system (Promega). Translation start codons were engineered at the beginning of each mutant. Mutations were con®rmed by DNA sequence analysis. Drawing is not to scale. (b) COS-7 cells were grown onto glass coverslips and transfected with 5 mg of CMV expression plasmids encoding c-Rel alone, or together with 5 mg of control CMV vector DNA or CMV expression plasmids for wild-type or mutant IkBa proteins with calcium-phosphate. At 48 h posttransfection, cells were analysed by immuno¯uorescence with anti-c-Rel antibody Ab1801, speci®c for the unique C-terminus of c-Rel (Kumar and GeÂ linas, 1993) . A minimum of 80 positivelystaining c-Rel-expressing cells was examined. Cells were photographed at a magni®cation of 6006. Representative ®elds are shown transfection of wild-type IkBa completely inhibited this eect. In a similar fashion, all of the IkBa mutants carrying deletions in the N-terminal domain led to the transcriptional inactivation of c-Rel, with the exception of mutant 87 ± 318. Notably, mutants that exhibited an inhibitory activity were those that associated eciently with c-Rel in co-immunoprecipitation assays. Conversely, mutant 87 ± 318 that failed to form a stable complex with c-Rel homodimers in co-immunoprecipitation assays exhibited a greatly reduced capacity to inhibit the transcriptional activity of c-Rel. The con®nement of c-Rel to the cytoplasm of cells coexpressing IkBa mutants 14 ± 318, 28 ± 318 or 48 ± 318 suggested that the inhibitory activity of these IkBa proteins resulted from their ability to block the nuclear accumulation of c-Rel (Figure 1b , panels d ± f). However, IkBa mutants 59 ± 318 and 76 ± 318 eciently suppressed c-Rel-mediated transactivation despite their inability to restrict c-Rel to the cytoplasm (Figure 3a and Figure 1b, panels g and h) . This pointed to the inhibition of c-Rel protein activity in the nucleus (see below).
IkBa is a potent inhibitor of c-Rel DNA-binding activity (Zabel and Baeuerle, 1990; Kerr et al., 1991) . Since the sequences of IkBa implicated in the suppression of Rel DNA binding generally correspond to those important for the transcriptional inactivation of c-Rel (Luque and GeÂ linas, 1998) , we postulated that the regulation of nuclear c-Rel activity by IkBa mutants 59 ± 318 and 76 ± 318 may result from the inhibition of c-Rel interaction with DNA. To test this hypothesis, IkBa mutants were analysed for their eects on c-Rel DNA binding in gel retardation assays. Extracts from COS-7 cells transfected with CMV-c-Rel alone showed signi®cant binding to an oligonucleotide probe containing a consensus NF-kB DNA site ( Figure  3b, lane 3) . In contrast, the co-expression of c-Rel with wild-type IkBa led to a complete inhibition of c-Rel DNA binding (lane 4). IkBa mutants that led to ecient accumulation of c-Rel in the cytoplasm also showed wild-type inhibitory activity toward c-Rel DNA binding (mutants 14 ± 318, 28 ± 318 or 48 ± 318; lanes 5 ± 7). Importantly IkBa mutants impaired for the cytoplasmic localization of c-Rel, but that nevertheless inhibited its transcriptional activity, were fully capable of blocking the interaction of c-Rel with DNA (mutants 59 ± 318 and 76 ± 318, lanes 8 and 9). As predicted IkBa mutant 87 ± 318, which was defective for association with c-Rel, failed to inhibit its binding to the probe. These results provided evidence that the inhibition of c-Rel-mediated transcription by IkBa mutants 59 ± 318 and 76 ± 318 indeed resulted from abrogation of c-Rel DNA binding, consistent with the role of the ankyrin and C-terminal PEST domains of IkBa in the nuclear regulation of c-Rel.
That successive N-terminal deletion of IkBa beyond amino acid 48 abolished the cytoplasmic localization of c-Rel suggested that speci®c IkBa sequences may be needed for this activity. Alternatively, it is possible that a certain length of sequence preceding the ®rst ankyrin domain of IkBa is sucient to sterically obstruct the cRel NLS or to promote nuclear export. To address this issue, a mutant IkBa protein was constructed with an internal deletion of amino acids 48 ± 58 (IkBaD48 ± 58). In contrast to wild-type IkBa, mutant D48 ± 58 was unable to accumulate c-Rel in the cytoplasm, as detected by immuno¯uorescence with an anti-c-Rel antibody (Figure 4a) . Notably, IkBa mutant D48 ± 58 was as competent as wild-type IkBa for association with c-Rel in co-immunoprecipitation assays (Figure 4b , top panel, compare lanes 3 and 4). Together, these results demonstrate that amino acids 48 ± 58 are essential for IkBa to block the nuclear localization of c-Rel dimers.
Our prior work showed that deletion of the 75 Nterminal residues from IkBa crippled its ability to con®ne c-Rel to the cytosol (Luque and GeÂ linas, 1998) . Here, we have re®ned the mapping of the IkBa determinants implicated in the cytoplasmic inactivation of c-Rel dimers. IkBa mutants deleted of up to 47 Nterminal amino acids exhibited wild-type ability to accumulate c-Rel in the cytoplasm (mutants 14 ± 318, 28 ± 318, 48 ± 318). In contrast, mutants carrying further deletions were defective, despite their wild-type interaction with c-Rel (mutants 59 ± 318, 76 ± 318). Our ®nding that mutant D48 ± 58 also failed to restrict c-Rel to the cytoplasm demonstrates that the sequences aected by this deletion are necessary to block the nuclear localization of c-Rel homodimers, but are Extracts (400 ± 600 mg) were immunoprecipitated as described (Luque and GeÂ linas, 1998) , using anti-c-Rel antibody Ab1801, speci®c for the unique C-terminus of c-Rel (Kumar and GeÂ linas, 1993) . Complexes were resolved on polyacrylamide-SDS gels and analysed by autoradiography. The position of c-Rel and of wildtype p40/IkBa is marked by arrows. A bracket indicates the position of p40/IkBa mutants. Bottom panel: Cell extracts were analysed by Western blot, using a polyclonal anti-IkBa/MAD3 antibody that recognizes the C-terminus of IkBa (sc-371; Santa Cruz Biotechnology). The position of exogenous wild-type p40/ IkBa is marked by an arrow. A bracket indicates the position of exogenous p40/IkBa mutants. The position of endogenous MAD-3/IkBa is also indicated dispensable for interaction with c-Rel. Secondary structure prediction ascribes an alpha-helical conformation to this sequence in p40/IkBa (QLVRELE-DIRL, amino acids 48 ± 58). These data argue against a model in which the inhibitory activity of IkBa would simply require a certain length of sequence upstream of the ®rst ankyrin repeat of IkBa to sterically mask the cRel NLS or to promote its nuclear export. These ®ndings on the functional regulation of full-length cRel protein dimers are consistent with and extend those of Latimer and co-workers looking at eects on the subcellular localization of p50/NF-kB1 and of a truncated c-Rel protein lacking the transactivation domain (c-RelDC; Latimer et al., 1998) .
The X-ray structure of crystals containing portions of p50/p65 NF-kB together with a fragment of IkBa was recently solved by two independent groups Jacobs and Harrison, 1998) . In both cases, the IkBa fragment lacked the N-terminal serine-rich domain. The N-terminus of the IkBa fragment used in the crystal structures corresponds roughly to that of IkBa mutant D76 ± 318 described in this study. The structure described by Jacobs and Harrison implicated the ®rst two ankyrin repeats of IkBa in an interaction with sequences in the vicinity of the p65 nuclear localization signal (Jacobs and Harrison, 1998; Baeuerle, 1998) . Unfortunately, the IkBa sequences shown here to be necessary to regulate the subcellular localization of c-Rel were not present in NF-kB/IkBa co-crystals. Nevertheless, the structure of the complex is compatible with a model in which the N-terminus of IkBa can easily fold back to mask the second Rel NLS in the dimer. In this scenario, the Nterminal domain of IkBa would act in concert with ankyrin repeats 1 and 2 to obstruct Rel NLS interactions with nuclear import factors (Jacobs and Harrison, 1998; Simeonidis et al., 1999) . This model is consistent with earlier work showing that the interaction of IkBa with NF-kB dimers of p50/p65 or c-Rel precluded NLS recognition by anti-NLS antibodies (Zabel et al., 1993) .
Since the second ankyrin repeat of IkBa functions as a nuclear import signal (Sachdev et al., 1998) , it is conceivable that deletion of N-terminal sequences in IkBa could perhaps alter its structure in a way that exposes its nuclear import sequence. In this context, the nuclear entry of c-Rel complexes would result from the import of the IkBa mutant complex. Several lines of evidence argue against this possibility. Since the integrity of the ankyrin domain is essential for the association of IkBa with Rel (mutant 87 ± 318; Inoue et al., 1992; Jaray et al., 1995) , alterations in the structure of the ankyrin domain would likely abrogate Rel-IkBa inter- Extracts (20 mg) from COS-7 cells transfected with CMV-c-Rel alone (lanes 3 and 11), or together with CMV expression vectors for wild-type (lane 4) or mutant IkBa proteins (lanes 5 ± 10), were analysed in gel retardation assays, as described (Xu and GeÂ linas, 1997) . Extracts were incubated with a 32 P-labeled oligonucleotide probe containing an NF-kB site derived from the IL6 enhancer, and resolved in 5% native polyacrylamide gels. Where indicated, DNA-bound complexes containing c-Rel were supershifted with anti-c-Rel antibody Ab1801 (lane 11). Arrows point to the positions of DNA-bound c-Rel complexes and the supershifted cRel/DNA complex. DNA-binding complexes endogenous to COS-7 cells were also detected in lanes 2 ± 11 actions. The observation that a cytoplasmic mutant of p50 was not driven to the nucleus upon association with an IkBa mutant lacking the N-terminal domain also argues against the nuclear entry of c-Rel-IkBa mutant complexes upon recognition of the nuclear import signal of IkBa (Latimer et al., 1998) . The N-terminus of IkBa does not contribute to the anity of IkBa for Rel/NF-kB dimers and Figures 2 and 4b) . Thus, it appears that deletion of IkBa residues 48 ± 58 may rather allow optimal exposure of the c-Rel NLS in (cRel) 2 -IkBa complexes. This hypothesis is supported by previous studies from this group, showing that c-Rel complexes containing wild-type IkBa were inaccessible to antibodies speci®c for the NLS subdomain (Luque and GeÂ linas, 1998) . In contrast, the antibody recognized the c-Rel NLS in complexes containing IkBa mutant 76 ± 318.
Since only one of the two NLS of a Rel dimer is sucient for nuclear translocation of the complex (Latimer et al., 1998) , the deletion of amino acids 48 ± 58 in IkBa may induce a more open conformation at the N-terminal end of IkBa to allow nuclear transport factors to access at least one of the Rel NLS in the dimer. Given that the nuclear translocation machinery is in competition with IkBa for binding to the Rel NLS region, the deletion of amino acids 48 ± 58 from IkBa may tip the balance in favor of the nuclear translocation machinery. However, we do not rule out the possibility that this sequence in IkBa may function to promote the nuclear export of Rel/IkBa complexes. Together, these ®ndings ascribe a novel function to the N-terminus of IkBa in the control of Rel localization to the cytoplasm. While ectopically-expressed IkBa localizes to the nucleus upon transfection (Zabel et al., 1993) , recent evidence indicates that the bulk of the inhibitory activity of endogenous IkBa factors in vivo resides in the cytoplasmic regulation of NF-kB complexes (Simeonidis et al., 1999) . It was estimated that only about 10% of endogenous IkBa activity serves to block NF-kB DNA binding in the nucleus. Thus in light of the recent implication of IkBa mutations in Hodgkin's lymphoma and of aberrant Rel/NF-kB activity in various cancers (Sovak et al., 1997; Cabannes et al., 1999; Rayet and GeÂ linas, 1999) , our ®ndings predict that certain mutations aecting the N-terminal domain of endogenous IkBa proteins may have severe biological consequences.
Note added in proof While this manuscript was being reviewed, a study showed that the determinants mapped herein function as a nuclear export signal (NES) in IkBa (Johnson et al., 1999) . 
